Mannitol Powder for DPI: Inhalation-Grade, cGMP, USP/EP Compliant

Mannitol, a naturally occurring sugar alcohol, has emerged as a preferred carrier in dry powder inhaler (DPI) formulations due to its excellent safety profile and physicochemical properties. Unlike lactose, mannitol is non-reducing, minimizing Maillard reactions with amine-containing drugs, thus enhancing stability. Its crystalline structure allows for precise control of particle size, which directly influences aerosol performance. For effective pulmonary delivery, particles must be in the 1–5 µm range for deep lung deposition, while larger carrier particles (50–100 µm) facilitate flow and dispersion. Our mannitol powder for dry powder inhaler is engineered to meet these criteria, offering consistent batch-to-batch performance. We employ advanced crystallization and milling techniques to achieve target particle size distributions, ensuring efficient detachment of drug particles from carriers during inhalation. Additionally, our mannitol exhibits low hygroscopicity, reducing moisture-induced aggregation and maintaining formulation integrity. With regulatory requirements becoming more stringent, choosing a reliable mannitol supplier is crucial. Our 33 years of expertise in corn processing and global export experience ensure that our mannitol meets the highest quality standards, backed by full documentation for regulatory submissions. Whether for asthma, COPD, or systemic delivery, our mannitol powder enhances DPI performance and patient outcomes.